IRON vs. MURA

In the year-to-date period, IRON achieves a -26.48% return, which is significantly lower than MURA's -18.01% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Disc Medicine Inc. (IRON) and Mural Oncology plc (MURA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current IRON Sharpe Ratio is 0.90, which is higher than the MURA Sharpe Ratio of -0.19. The chart below compares the historical Sharpe Ratios of IRON and MURA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither IRON nor MURA has paid dividends to shareholders.

The maximum IRON drawdown since its inception was -96.68%, which is greater than MURA's maximum drawdown of -83.44%. Use the drawdown chart below to compare losses from any high point for IRON and MURA. For additional features, visit the drawdowns tool.

The current volatility for Disc Medicine Inc. (IRON) is 19.46%, while Mural Oncology plc (MURA) has a volatility of 85.50%. This indicates that IRON experiences smaller price fluctuations and is considered to be less risky than MURA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Disc Medicine Inc. and Mural Oncology plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.